Early evaluation of effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer

被引：0

作者：

Kramer, A. ^{[1
]}

Greuter, M. J. ^{[1
]}

Schraa, S. ^{[2
]}

Vink, G. R. ^{[2
]}

Phallen, J. ^{[3
]}

Velculescu, V. ^{[3
]}

Meijer, G. ^{[4
]}

Van den Broek, D. ^{[5
]}

Koopman, M. ^{[2
]}

Roodhart, J. M. L. ^{[2
]}

Fijneman, R. ^{[4
]}

Retel, V. P. ^{[6
]}

Coupe, V. ^{[1
]}

机构：

[1] Amsterdam UMC, Epidemiol & Data Sci, Locatie VUmc, Amsterdam, Netherlands

[2] Univ Med Ctr Utrecht UMCU, Med Oncol Dept, Utrecht, Netherlands

[3] Johns Hopkins Med, Med Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[4] Antoni van Leeuwenhoek Hosp, Pathol, NKI AVL Netherlands Canc Inst, Amsterdam, Netherlands

[5] Antoni van Leeuwenhoek Hosp, Dept Lab Med, NKI AVL Netherlands Canc Inst, Amsterdam, Netherlands

[6] Antoni van Leeuwenhoek Hosp, Psychosocial Res & Epidemiol, NKI AVL Netherlands Canc Inst, Amsterdam, Netherlands

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.2888

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

164P

引用

页码：S247 / S247

页数：1

共 50 条

[1] Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer
Kramer, Astrid
Greuter, Marjolein J. E.
Schraa, Suzanna J.
Vink, Geraldine R.
Phallen, Jillian
Velculescu, Victor E.
Meijer, Gerrit A.
van den Broek, Daan
Koopman, Miriam
Roodhart, Jeanine M. L.
Fijneman, Remond J. A.
Retel, Valesca P.
Coupe, Veerle M. H.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
[2] Cost-Effectiveness of Adjuvant Chemotherapy in the Treatment of Early-Stage Colon Cancer
Soni, Amy
Chu, Edward
CLINICAL COLORECTAL CANCER, 2015, 14 (04) : 219 - 226
[3] MODEL-BASED EFFECTIVENESS AND COST-EFFECTIVENESS OF PERSONALIZED SELECTION STRATEGIES FOR ADJUVANT CHEMOTHERAPY IN STAGE II COLON CANCER
Jongeneel, Gabrielle
Greuter, Marjolein J. E.
van Erning, Felice N.
Koopman, Miriam
Vink, Geraldine R.
Punt, Cornelis J. A.
Coupe, Veerle M. H.
MEDICAL DECISION MAKING, 2020, 40 (01) : E80 - E81
[4] Cost-effectiveness of adjuvant chemotherapy in early stage breast cancer
John, Preethi
Bannuru, Raveendhara R.
Cohen, Joshua T.
Buchsbaum, Rachel J.
Erban, John Kalil
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[5] Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
Jongeneel, Gabrielle
Greuter, Marjolein J. E.
van Erning, Felice N.
Koopman, Miriam
Vink, Geraldine R.
Punt, Cornelis J. A.
Coupe, Veerle M. H.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
[6] Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa
Tan, Sarah Xinhui
Pumpalova, Yoanna
Rogers, Alexandra M. M.
Bhatt, Kishan
Herbst, Candice-lee
Ruff, Paul
Neugut, Alfred I. I.
Hur, Chin
CANCER MEDICINE, 2023, 12 (14): : 15515 - 15529
[7] Cost-Effectiveness of Adjuvant FOLFOX and 5FU/LV Chemotherapy for Patients with Stage II Colon Cancer
Ayvaci, Mehmet U. S.
Shi, Jinghua
Alagoz, Oguzhan
Lubner, Sam J.
MEDICAL DECISION MAKING, 2013, 33 (04) : 521 - 532
[8] Cost-effectiveness of adjuvant therapy for treatment of stage II colon cancer in patients with diabetes.
Dinh, T.
Alperin, P.
O'Neil, B. H.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[9] Cost-effectiveness of adjuvant chemotherapy for patients with high-risk stage II and stage III colon cancer in South Africa.
Pumpalova, Yoanna S.
Rogers, Alexandra M.
Tan, Sarah Xinhui
Herbst, Candice-Lee
Ruff, Paul
Neugut, Alfred I.
Hur, Chin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[10] CAPOX VERSUS MFOLFOX AS ADJUVANT CHEMOTHERAPY IN PATIENTS WITH STAGE 3 COLON CANCER: A COST-EFFECTIVENESS STUDY
Abuloha, S.
Li, P.
Bian, J.
Guo, Y.
Shao, H.
VALUE IN HEALTH, 2022, 25 (07) : S370 - S370

← 1 2 3 4 5 →